Consider clinically relevant drug interactions when prescribing edoxaban

被引：0
|
作者：
Esther S. Kim
Young-A Heo
机构：
[1] Springer Nature,
来源：
Drugs & Therapy Perspectives | 2021年 / 37卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Edoxaban, a factor Xa inhibitor, is a direct oral anticoagulant (DOAC). DOACs may have a lower incidence of drug-drug interactions (DDIs) than vitamin K antagonists such as warfarin. Nonetheless, DOACs can have clinically relevant pharmacokinetic and pharmacodynamic DDIs. Careful consideration of potential DDIs is needed when prescribing edoxaban, and clinically relevant DDIs may be prevented by avoiding offending combinations, spacing out the timing of the drugs or by halving the dose of edoxaban where indicated.
引用
收藏
页码：115 / 119
页数：4
相关论文
共 50 条
  • [41] CLINICALLY RELEVANT INTERACTIONS BETWEEN CARDIOVASCULAR DRUGS, HERBALS AND FRUIT JUICES: MECHANISMS OF INTERACTIONS AND PRESCRIBING STRATEGIES
    Buttar, H.
    CARDIOLOGY, 2018, 140 : 74 - 74
  • [42] Identification of clinically actionable drug-drug-gene interactions that impact pharmacogenomic prescribing
    Lee, Yee Ming
    Agolini, Emanuele
    Danahey, Keith
    Yukman, Patrick
    Borden, Brittany
    Leung, Edward
    Yeo, Kiang-Teck
    O'Donnell, Peter
    Ratain, Mark
    PHARMACOTHERAPY, 2016, 36 (12): : E266 - E267
  • [43] What to consider when prescribing psychotropic medications
    Lippi, G.
    SOUTH AFRICAN JOURNAL OF PSYCHIATRY, 2015, 21 (03) : 112 - 112
  • [44] IMPACT OF THE DRUG-DRUG INTERACTION DATABASE SFINX ON THE PREVALENCE OF CLINICALLY RELEVANT DRUG INTERACTIONS
    Andersson, M. L.
    Eiermann, B.
    Wettermark, B.
    Bottiger, Y.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 105 : 138 - 138
  • [45] “Klinisch bedeutsame” neue Arzneimittelinteraktionen“Clinically relevant” new drug interactions
    Uwe Fuhr
    Medizinische Klinik, 1999, 94 (2) : 120 - 124
  • [46] DGIdb 2.0: mining clinically relevant drug-gene interactions
    Wagner, Alex H.
    Coffman, Adam C.
    Ainscough, Benjamin J.
    Spies, Nicholas C.
    Skidmore, Zachary L.
    Campbell, Katie M.
    Krysiak, Kilannin
    Pan, Deng
    McMichael, Joshua F.
    Eldred, James M.
    Walker, Jason R.
    Wilson, Richard K.
    Mardis, Elaine R.
    Griffith, Malachi
    Griffith, Obi L.
    NUCLEIC ACIDS RESEARCH, 2016, 44 (D1) : D1036 - D1044
  • [47] Clinically relevant drug interactions with orally administered targeted antitumor agents
    Lipp, H. -P.
    ONKOLOGE, 2013, 19 (10): : 870 - 877
  • [48] Clinically relevant drug interactions between anticancer drugs and psychotropic agents
    Yap, K. Y. -L.
    Tay, W. L.
    Chui, W. K.
    Chan, A.
    EUROPEAN JOURNAL OF CANCER CARE, 2011, 20 (01) : 6 - 32
  • [49] Clinically relevant drug interactions between newer antidepressants and oral anticoagulants
    Spina, Edoardo
    Barbieri, Maria Antonietta
    Cicala, Giuseppe
    Bruno, Antonio
    de Leon, Jose
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2020, 16 (01) : 31 - 44
  • [50] Clinically Relevant Pharmacokinetic Herb-drug Interactions in Antiretroviral Therapy
    Fasinu, Pius S.
    Gurley, Bill J.
    Walker, Larry A.
    CURRENT DRUG METABOLISM, 2016, 17 (01) : 52 - 64
12345